Infectious Diseases (except HIV/AIDS)
-
Pathophysiological Response to SARS-CoV-2 Infection Detected by Infrared Spectroscopy Enables Rapid and Robust Saliva Screening for COVID-19
This article has 15 authors:Reviewed by ScreenIT
-
Serum anti-Spike antibody titers before and after heterologous booster with mRNA-1273 SARS-CoV-2 vaccine following two doses of inactivated whole-virus CoronaVac vaccine
This article has 17 authors:Reviewed by ScreenIT
-
Evaluation of the Implementation of the 4C Mortality Score in United Kingdom hospitals during the second pandemic wave
This article has 35 authors:Reviewed by ScreenIT
-
Neutralizing antibody activity against 21 SARS-CoV-2 variants in older adults vaccinated with BNT162b2
This article has 16 authors:Reviewed by ScreenIT
-
Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant
This article has 14 authors:Reviewed by ScreenIT
-
Healthcare Workers’ SARS-CoV-2 Omicron Variant Uncertainty-Related Stress, Resilience, and Coping Strategies during the First Week of the World Health Organization’s Alert
This article has 23 authors:Reviewed by ScreenIT
-
Saliva swabs are the preferred sample for Omicron detection
This article has 9 authors:Reviewed by ScreenIT
-
Relative Importance of Various Inflammatory Markers and Their Critical Thresholds for COVID-19 Mortality
This article has 1 author:Reviewed by ScreenIT
-
Effectiveness of BNT162b2 and mRNA-1273 Second Doses and Boosters for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and SARS-CoV-2–Related Hospitalizations: A Statewide Report From the Minnesota Electronic Health Record Consortium
This article has 17 authors:Reviewed by ScreenIT
-
SARS-CoV-2 Vaccine Alpha and Delta Variant Breakthrough Infections Are Rare and Mild but Can Happen Relatively Early after Vaccination
This article has 28 authors:Reviewed by ScreenIT